Downregulation of telomerase activity in human promyelocytic cell line using RNA interference

Annals of Hematology

Volumn 88, Issue 12, 2009, Pages 1169-1176

  Miri Moghaddam, E ^a,b   Deezagi, A ^a   Soheili, Z S ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell proliferation; HL 60; hTERT; siRNA; Telomerase

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; FLOW CYTOMETRY; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN RNA BINDING; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSIENT TRANSFECTION;

CELL PROLIFERATION; DOWN-REGULATION; HL-60 CELLS; HUMANS; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TELOMERASE; TRANSFECTION;

EID: 70350295878     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0748-0     Document Type: Article

References (46)

1. Zakian VA (1995) Telomeres: Beginning to understand the end. Science 270:1601-1607. doi: 10.1126/science.270.5242.1601
2. McEachern MJ, Krauskopf A, Blackburn EH (2000) Telomeres and their control. Annu Rev Genet 34:331-358. doi: 10.1146/annurev.genet.34.1.331
3. Oulton R, Harrington L (2000) Telomeres, telomerase, and cancer: Life on the edge of genomic stability. Curr Opin Oncol 12:74-81. doi: 10.1097/ 00001622-200001000-00013
4. Hoeijmakers JHJ (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374. doi: 10.1038/35077232
5. Wright WE, Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27:383-389. doi: 10.1016/ 0531-5565(92)90069-C
6. Blackburn EH (1992) Telomerases. Annu Rev Biochem 61:113-129. doi: 10.1146/annurev.bi.61.070192.000553
7. Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65:337-365. doi: 10.1146/annurev.bi.65.070196.002005
8. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE et al (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17:498-502. doi: 10.1038/ng1297-498
9. Nakayama JI, Tahara H, Tahara E, Saito M, Ito K, Nakamura H et al (1998) Telomerase activation by HTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18:65-68. doi: 10.1038/ng0198-65
10. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352. doi: 10.1126/science.279.5349.349
11. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015. doi: 10.1126/science.7605428
12. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M et al (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21:111-114. doi: 10.1038/5056
13. Zhang TC, Schmitt MT, Mumford JL (2003) Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro. Carcinogenesis 24:1811-1817. doi: 10.1093/carcin/bgg141
14. Liu L, Berletch JB, Green JG, Pate MS, Andrews LG, Tollefsbol TO (2004) Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation. Mol Cancer Ther 3:1003-1009
15. Liu J-J, Wu X-Y, Peng J, Pan X-L, Lu H-L (2004) Antiproliferation effects of oridonin on HL-60 cells. Ann Hematol 83:691-695. doi: 10.1007/ s00277-004-0919-y
16. Yamaguchi T, Takahashi H, Harada Y, Yoshikawa M, Iyono S, Inomata M et al (2004) Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs. Nucleic Acids Symp Ser 48:187-188. doi: 10.1093/ nass/48.1.187
17. Pizzimenti S, Briatore F, Laurora S, Toaldo C, Maggio M, De Grandi M et al (2006) 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radic Biol Med 40:1578-1591. doi: 10.1016/j.freeradbiomed.2005.12.024
18. Wang F, Sun L, Sun H, Fan Q, Le X, Zhang Q (2007) Inhibition hTERT antisense oligodeoxynucleotide changes proliferation and telomerase activity of HL-60 cell. Life Sci J 4:17-21
19. Hannon GJ (2002) RNA interference. Nature 418:244-251. doi: 10.1038/ 418244a
20. Hammond SM, Caudy AA, Hannon GJ (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2:110-119. doi: 10.1038/ 35052556
21. Zhang PH, Zou L, Tu ZG (2006) RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 131:143-149. doi: 10.1016/j.jss.2005.09.017
22. Gandellini P, Folini M, Bandiera R, De Cesare M, Binda M, Veronese S et al (2007) Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Biochem Pharmacol 73:1703-1714. doi: 10.1016/ j.bcp. 2007.01.035
23. De Souza Nascimento P, Alves G, Fiedler W (2006) Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol Rep 16:423-428
24. Zheng JN, Sun YF, Pei DS, Liu JJ, Chen JC, Li W, Sun XQ, Shi QD, Han RF, Ma TX (2006) Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs. Acta Biochim Biophys Sin (Shanghai) 38:500-506. doi: 10.1111/ j.1745-7270.2006.00182.x
25. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, Munshi NC, Goyal RK (2005) Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: Mechanism and therapeutic potential. Mol Cancer 4:24. doi: 10.1186/1476-4598-4-24
26. Ning S, Fuessel S, Kotzsch M, Kraemer K, Kappler M, Schmidt U et al (2004) siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth. Int J Oncol 25:1065-1071
27. Tebes SJ, Johnson NC, Fiorica JV, Kruk PA (2005) Inhibition of telomerase in ovarian cancer using siRNA technology. J Clin Oncol 23:3182 Meeting abstracts
28. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326-330. doi: 10.1038/nbt936
29. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159. doi: 10.1016/0003-2697(87)90021-2
30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408
31. Lin Y, Miyamoto N, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y (1996) Telomerase activity in human bladder cancer. Clin Cancer Res 2:929-932
32. Ohyashki J, Sashida G, Tauchi T, Ohyashiki K (2002) Telomeres and telomerase in hematologic neoplasia. Oncogene 21:680-687. doi: 10.1038/ sj.onc.1205075
33. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M (2000) Sp-1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28:669-677. doi: 10.1093/nar/28.3.669
34. Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R (2008) Multistep regulation of telomerase during differentiation of HL-60 cells. J Leukoc Biol 83:1-9
35. Guittat L, Alberti P, Gomez D, De Cian A, Pennarun G, Lemarteleur T et al (2004) Targeting human telomerase for cancer therapeutics. Cytotechnology 45:75-90. doi: 10.1007/s10616-004-5127-z
36. Saretzki G (2003) Telomerase inhibition as cancer therapy. Cancer Lett 194:209. doi: 10.1016/S0304-3835(02)00708-5
37. Wang Q, Liu M, Kozasa T, Rothestein JD, Sternweis PC, Neubig RR (2004) Ribozyme and siRNA-mediated suppression of RGS-containing RhoGEF proteins. Methods Enzymol 389:244-265. doi: 10.1016/S0076-6879(04)89015-3
38. Lu PY, Xie FY, Woodle MC (2003) siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Curr Opin Mol Ther 5:225-234
39. Kosciolek BA, Kalantidis K, Tabler M, Rowley PT (2003) Inhibition of telomerase activity in human cancer cells by RNA interference. Mol Cancer Ther 2:209-216
40. Hu B, Insel RA (1999) Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of telomerase catalytic subunit. Eur J Immunol 29:3745-3753. doi: 10.1002/ (SICI)1521-4141(199911)29:11<3745::AID-IMMU3745>3.0.CO;2-1
41. Nowak T, Januszkiewicz D, Zawada M, Pernak M, Lewandowski K, Rembowska J et al (2006) Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase. Oncol Rep 16:301-305
42. Casillas MA Jr, Brotherton SL, Andrews LG, Ruppert JM, Tollefsbol TO (2003) Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316:57-65. doi: 10.1016/S0378-1119(03)00739-X
43. Zou L, Zhang P, Luo C, Tu Z (2006) shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity. Cancer Chemother Pharmacol 57:328-334. doi: 10.1007/s00280-005-0056-x
44. Zou L, Zhang PH, Luo CL, Tu ZG (2005) Transcript regulation of human telomerase reverse transcriptase by c-myc and mad1. Acta Biochim Biophys Sin (Shanghai) 37:32-38
45. Lai SR, Cunningham AP, Huynh VQ, Andrews LG, Tollefsbol TO (2007) Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop. Exp Cell Res 313:322-330. doi: 10.1016/ j.yexcr.2006.10.014
46. Huh HJ, Huh JW, Yoo ES, Seong CM, Lee M, Hong KS, Chung WS (2005) hTERT mRNA levels by real-time RT-PCR in acute myelogenous leukemia. Am J Hematol 79:267-273. doi: 10.1002/ajh.20394